University of Ioannina
Επιγενετικές αλλοιώσεις στο καρκίνωμα του παχέος εντέρου και συσχέτιση αυτών με διαβητικούς ασθενείς
Abstract
dc:descriptionINTRODUCTION: Epigenetics refers to the ways the environment can influence the expression of genes without structural gene changes. Epigenetic mechanisms include DNA methylation, histone modifications and non-coding RNAs. They all play important roles in chromatin structure and gene expression and are thoroughly studied in serious diseases such as colorectal cancer (CRC) and Type 2 Diabetes Mellitus (T2DM). MATERIALS AND METHODS: The aim of the study was the microscopic and macroscopic characteristics of colorectal cancer tissues, along with the expression of TET2 and GST3 proteins and the possible correlation of these results with the comorbidity of T2DM. Malignant colon tumors from 46 patients were fixed in formaldehyde solution and embedded in paraffin blocks. Hematoxylin-Eosin histochemical staining was performed and their microscopic characteristics were studied. This was followed by the immunohistochemical study of TET2 and GST3 expression by two independent researchers. Differences in interpretation were assessed by re-examining the slides together under a binocular microscope. The results were recorded, statistically analyzed and correlated with T2DM as comorbidity. IBM® SPSS® Statistics 23 program was used for statistical analysis. RESULTS: All tumors showed GST3 expression at three levels (weak, moderate, strong) and approximately two out of three tumors showed TET2 expression at two levels (weak, moderate). Patients not suffering from T2DM had a statistically significantly higher percentage of weak/no expression of TET2 (p=0.038). In contrast, diabetic patients showed a statistically significantly higher percentage of strong/moderate expression of GST3 (p=0.034). On binomial logistic regression, tumors excised from T2DM patients were approximately 7 times more likely to have moderate (rather than weak and none) TET2 expression compared to tumors from non-diabetic patients (OR 6,9, CI 1.33-35.75), and a 2.7-fold higher relative likelihood of showing strong (rather than moderate and weak) GST3 expression than tumors derived from non-diabetic patients (OR 2.7, CI 0.63, 12.09) taking into account sex, age and tumor size. The association between T2DM and the group of maximum observed TET2 expression remains statistically significant in additional binomial analysis that was performed taking into account the histological characteristics of the tumors of the study population (OR: 4.3, CI 1.09 – 17.4). In a similar analysis for GST3, the results were close to statistical significance. CONCLUSIONS: TET2 and GST3 are highly expressed in malignant colon tumors. History of T2DM in CRC patients was associated with the highest observed GST3 expression and the absence of T2DM was associated with the lowest observed TET2 expression in the studied tumors. T2DM increases the probability of observing GST3 and – especially – TET2 expression at maximum levels, independent of specific tumor microscopic features and patient demographics.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papadatos, Stamatis
- Παπαδάτος, Σταμάτης
Subjects
dc:subject × 21- Επιγενετική
- Ορθοκολικός καρκίνος
- Σακχαρώδης Διαβήτης (ΣΔ)
- ten-eleven translocation 2 (TET2)
- glutathione S-transferase Pi (GSTP)
- glutathione S-transferase 3 (GST3)
- Epigenetics
- Colorectal cancer
- Diabetes mellitus
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ιστολογία
- Παθολογοανατομία
- Κλινική Ιατρική
- Ενδοκρινολογία, Διαβήτης και Μεταβολισμός
- Basic Medicine
- Medical and Health Sciences
- Histology
- Pathology
- Clinical Medicine
- Endocrinology, Diabetes and Metabolism
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52542